Nova Leap Health Corp. (TSXV:NLH)

Nova Leap Health Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	28	24	24	26	22	48
Market Cap Growth	40.91%	3.70%	-8.85%	20.00%	-55.44%	-1.71%
Enterprise Value	29.91	25.58	24.4	26	23.83	52.46
Last Close Price	0.32	0.28	0.27	0.30	0.25	0.61
PE Ratio	-	-100.00	11.88	-19.17	-18.00	24.00
Forward PE	-	-	-	-	6.16	16.07
PS Ratio	0.65	0.78	0.92	0.99	0.76	2.27
PB Ratio	1.07	1.28	1.29	1.42	1.15	2.62
P/TBV Ratio	1.47	1.28	1.28	1.42	1.09	2.56
P/FCF Ratio	-	15.71	17.30	12.16	22.70	22.19
P/OCF Ratio	13.09	15.71	16.98	12.00	21.11	22.19
EV/Sales Ratio	0.69	0.81	0.95	0.99	0.84	2.47
EV/EBITDA Ratio	11.25	-93.71	-87.13	61.18	9.85	25.06
EV/EBIT Ratio	19.73	-23.13	-28.25	-56.50	22.43	42.60
EV/FCF Ratio	-	16.44	17.90	12.23	25.09	24.06
Debt / Equity Ratio	0.14	0.14	0.12	0.06	0.19	0.31
Debt / EBITDA Ratio	-10.74	-10.74	-9.02	3.08	1.60	2.92
Debt / FCF Ratio	1.88	1.88	1.85	0.62	4.09	2.80
Net Debt / Equity Ratio	0.08	0.08	0.06	0.02	0.14	0.24
Net Debt / EBITDA Ratio	-5.27	-5.27	-4.01	0.97	1.08	2.09
Net Debt / FCF Ratio	0.92	0.92	0.82	0.19	2.74	2.01
Asset Turnover	1.37	1.37	1.19	1.17	1.11	0.96
Quick Ratio	0.89	0.89	0.96	1.43	0.92	0.91
Current Ratio	0.96	0.96	1.06	1.59	1.00	0.96
Return on Equity (ROE)	-1.02%	-1.02%	7.56%	-5.72%	-4.50%	12.43%
Return on Assets (ROA)	-14.41%	-14.41%	-3.49%	-1.92%	2.41%	6.29%
Return on Invested Capital (ROIC)	-16.55%	-16.55%	-3.96%	-2.14%	2.71%	7.42%
Return on Capital Employed (ROCE)	-5.69%	-5.69%	-4.51%	-2.36%	5.24%	7.26%
Earnings Yield	-0.93%	-1.00%	8.42%	-5.22%	-5.56%	4.17%
FCF Yield	-	6.37%	5.78%	8.22%	4.41%	4.51%
Buyback Yield / Dilution	-0.60%	-0.60%	-0.68%	-5.83%	-4.90%	-16.89%
Total Shareholder Return	-0.60%	-0.60%	-0.68%	-5.83%	-4.90%	-16.89%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.